Sabra Health Care REIT (SBRA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual meeting scheduled for June 17, 2026, at company headquarters in Tustin, CA.
Shareholders are invited to vote on director elections, auditor ratification, and executive compensation.
Voting can be done online, by mail, or in person at the meeting.
Voting matters and shareholder proposals
Election of seven directors is proposed, with all nominees recommended by the board.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers.
Other business may be transacted as may properly come before the meeting.
Board of directors and corporate governance
Seven director nominees listed: Craig A. Barbarosh, Katie Cusack, Michael J. Foster, Lynne S. Katzmann, Ann Kono, Jeffrey A. Malehorn, Richard K. Matros.
Board recommends voting in favor of all director nominees.
Latest events from Sabra Health Care REIT
- Proxy covers director elections, auditor ratification, and performance-based executive pay.SBRA
Proxy filing24 Apr 2026 - Q4 2025 saw strong managed senior housing growth and robust 2026 guidance for ~5% FFO/AFFO growth.SBRA
Q4 202517 Apr 2026 - 2024 guidance raised as managed senior housing and FFO/AFFO growth accelerate.SBRA
Q2 20242 Feb 2026 - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 202417 Jan 2026 - 2024 saw strong AFFO growth and margins, with 2025 guidance projecting further FFO gains.SBRA
Q4 20248 Dec 2025 - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SBRA
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, strong senior housing growth, and raised 2025 guidance.SBRA
Q2 202523 Nov 2025 - Q1 2025 delivered higher earnings, strong FFO, and robust liquidity with major deals pending.SBRA
Q1 202519 Nov 2025